3
Fulminating vasculitis in a homozygous C2-deficient patient 1 Ralph E. Bennett, M.D. 2 John D. Clough, M.D. Leonard H. Calabrese, D.O. Homozygous C2 deficiency is associated with a va- riety of autoimmune diseases, but has never been de- scribed in association with acute necrotizing vasculitis. The authors observed such a case involving a 55-year- old white man who presented with a five-week history of progressive digital gangrene. There was no clinical or laboratory evidence of systemic lupus erythematosus or other connective tissue disease. Angiography sup- ported the diagnosis of obliterative vasculitis involving arteries of both medium and small caliber. High levels of immune complexes were detected, documented by Clq binding and cryoprecipitation. Total hemolytic complement activity was undetectable. Assays of indi- vidual complement components revealed absence of C2. Evidence of participation of the complement sys- tem in mediation of vascular inflammation was sup- ported by demonstration of C3 activation products using two-dimensional electrophoresis; in view of the normal C4 levels, this suggests activation of an alter- nate pathway. It would appear that acute complement- mediated vascular inflammation can occur in the ab- sence of an early component of the standard pathway. Index term: Vasculitis Cleve Clin Q 52:213-215, Summer 1985 1 Departments of Rheumatic Disease and Immunopathology, The Cleveland Clinic Foundation. Submitted for publication Nov 1984; accepted Feb 1985. 2 Current location: The Arthritis Center, Ltd., Phoenix, Ariz. sjh 0009-8787/85/02/0213/03/$l .75/0 Copyright © 1985, The Cleveland Clinic Foundation Deficiency of the C2 component of comple- ment is the most common type. While many C2-deficient individuals have no serious medical problems, some may have a variety of autoim- mune diseases, particularly systemic lupus ery- thematosus (SLE). 1 Other associated diseases may include Henoch-Schonlein purpura, derma- tomyositis, membranoproliferative glomerulo- nephritis, inflammatory bowel disease, and infec- tion. 1-12 While there has been a report of a C2- deficient patient with chronic vasculitis who had Raynaud's phenomenon, arthralgia, and foot drop, 8 we believe this is the first reported case of C2 deficiency in fulminating vasculitis. Case Report A 55-year-old white man was admitted to the Cleveland Clinic for evaluation of digital gangrene. He had been well until five weeks earlier, when his right index finger became cold and painful. Over the next few weeks, the tips of his right ring finger and both index fingers became necrotic, while his other fingertips became cyanotic. His history re- vealed long-standing cirrhosis, as well as a portacaval shunt in 1975, and he had smoked one pack of cigarettes a day for 35 years. On admission, his orientation was good and his vital signs were stable. The Allen test was abnormal on the left; other pulses were within normal limits. Fundal examination was normal, and there were no splinter hem- orrhages. Cardiac examination showed a III/VI holosystolic murmur at the left sternal border, unchanged from a year earlier. A complete blood count was normal, with 147,000 plate- lets. Urinalysis was normal. Blood urea nitrogen was 37 mg/ 100 mL (14.8 mmol/L); creatinine, 2.2 mg/100 mL (194 /¿mol/L); and serum electrolytes, normal except for a sodium level of 129 mEq/L. Total bilirubin was 2.0 mg/100 mL (36 fim/L); other liver enzymes were normal. The Wester- gren sedimentation rate was 24 mm/hr, and the latex fixa-

Fulminating vasculiti ins a homozygous C2-deficient patient...pathway coul explaid thn e fulminatin vasculitig s seen in our patient. Leonard H. Calabrese D.O, . Department of Rheumati

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Fulminating vasculiti ins a homozygous C2-deficient patient...pathway coul explaid thn e fulminatin vasculitig s seen in our patient. Leonard H. Calabrese D.O, . Department of Rheumati

Fulminating vasculitis in a homozygous C2-deficient patient1

Ralph E. Bennett, M.D.2

John D. Clough, M.D. Leonard H. Calabrese, D.O.

Homozygous C2 deficiency is associated with a va-riety of autoimmune diseases, but has never been de-scribed in association with acute necrotizing vasculitis. The authors observed such a case involving a 55-year-old white man who presented with a five-week history of progressive digital gangrene. There was no clinical or laboratory evidence of systemic lupus erythematosus or other connective tissue disease. Angiography sup-ported the diagnosis of obliterative vasculitis involving arteries of both medium and small caliber. High levels of immune complexes were detected, documented by Clq binding and cryoprecipitation. Total hemolytic complement activity was undetectable. Assays of indi-vidual complement components revealed absence of C2. Evidence of participation of the complement sys-tem in mediation of vascular inflammation was sup-ported by demonstration of C3 activation products using two-dimensional electrophoresis; in view of the normal C4 levels, this suggests activation of an alter-nate pathway. It would appear that acute complement-mediated vascular inflammation can occur in the ab-sence of an early component of the standard pathway.

Index term: Vasculitis Cleve Clin Q 52:213-215, Summer 1985

1 Departments of Rheumatic Disease and Immunopathology, The Cleveland Clinic Foundation. Submitted for publication Nov 1984; accepted Feb 1985.

2 Current location: The Arthritis Center, Ltd., Phoenix, Ariz. sjh

0009-8787/85/02/0213/03/$l .75/0

Copyright © 1985, The Cleveland Clinic Foundation

Deficiency of the C2 component of comple-ment is the most common type. While many C2-deficient individuals have no serious medical problems, some may have a variety of autoim-mune diseases, particularly systemic lupus ery-thematosus (SLE).1 Other associated diseases may include Henoch-Schonlein purpura, derma-tomyositis, membranoproliferative glomerulo-nephritis, inflammatory bowel disease, and infec-tion.1-12 While there has been a report of a C2-deficient patient with chronic vasculitis who had Raynaud's phenomenon, arthralgia, and foot drop,8 we believe this is the first reported case of C2 deficiency in fulminating vasculitis.

Case Report A 55-year-old white man was admitted to the Cleveland

Clinic for evaluation of digital gangrene. He had been well until five weeks earlier, when his right index finger became cold and painful. Over the next few weeks, the tips of his right ring finger and both index fingers became necrotic, while his other fingertips became cyanotic. His history re-vealed long-standing cirrhosis, as well as a portacaval shunt in 1975, and he had smoked one pack of cigarettes a day for 35 years. On admission, his orientation was good and his vital signs were stable. The Allen test was abnormal on the left; other pulses were within normal limits. Fundal examination was normal, and there were no splinter hem-orrhages. Cardiac examination showed a III/VI holosystolic murmur at the left sternal border, unchanged from a year earlier.

A complete blood count was normal, with 147,000 plate-lets. Urinalysis was normal. Blood urea nitrogen was 37 mg/ 100 mL (14.8 mmol/L); creatinine, 2.2 mg/100 mL (194 /¿mol/L); and serum electrolytes, normal except for a sodium level of 129 mEq/L. Total bilirubin was 2.0 mg/100 mL (36 fim/L); other liver enzymes were normal. The Wester-gren sedimentation rate was 24 mm/hr, and the latex fixa-

Page 2: Fulminating vasculiti ins a homozygous C2-deficient patient...pathway coul explaid thn e fulminatin vasculitig s seen in our patient. Leonard H. Calabrese D.O, . Department of Rheumati

214 Cleveland Clinic Quar ter ly Vol. 52, No. 2

Fig. Appearance of the patient's fingers late in his hospital course.

t ion t i te r 1:640. Cryog lobu l ins were 113 ntg/mL (normal , < 5 0 ) , inc lud ing C 3 a n d polyclonal IgC, IgA, a n d IgM. Clq b i n d i n g assay showed 4 8 1 U / m L (no rma l , < 6 2 ) ; C 3 was 9 8 m g % (normal , 8 3 - 1 6 9 ) , C 4 was 19.5 m g % (norma l , 2 4 - 5 1 ) , a n d C H 5 0 was marked ly dep re s sed (3 U). A N A , a n t i - D N A , a n d anti-F.NA w e r e all negat ive . Fac to r B was 6 m g / 1 0 0 m L (normal , 12 -30 ) . Us ing two-dimens iona l I m m u n o e l e c t r o -phoresis , ac t ivated C 3 was f o u n d t o be 18 m g % of total an t igen ic C 3 (normal , < 1 0 % ) . H B s A G was nega t ive , as were mul t ip le b lood cu l tu res .

A f t e r ident i f ica t ion of C2 d e f i c i e n c y , " C 3 act ivat ion was assessed by two-d imens iona l i m m u n o e l e c t r o p h o r e s i s 1 4 in or-d e r to d i f f e r e n t i a t e B l c (native C3) f r o m B l a (activated). C 3 a n d C4 were m e a s u r e d by n e p h e l a m e t r y a n d f ac to r B by r a d i o i m m u n o d i f f u s i o n . T o t a l hemoly t i c c o m p l e m e n t was m e a s u r e d in t h e s t a n d a r d m a n n e r 1 0 ( no rma l r a n g e in o u r l abo ra to ry , 7 0 - 1 9 0 C H 5 0 U / m L ) .

Fol lowing hepa r in iza t ion , e c h o c a r d i o g r a p h y c o m b i n e d with ca rd iac ca the te r i za t ion r evea l ed n o s o u r c e of embol i . A n g i o g r a m s of t he left h a n d a n d a r m s h o w e d t a p e r i n g a n d occlusion of t h e left u l n a r a r t e r y 5 cm p rox ima l to t h e styloid process , as well as occlusion of several in terdigi ta l a r t e r ies . O t h e r digits subsequen t ly b e c a m e necro t i c as well (Fig). P lasmapheres i s was a t t e m p t e d several t imes, bu t be-cause of p o o r vascular access was successful only once . Ora l cyc lophosphamide (Cytoxan , Mead J o h n s o n ) was adminis -t e r e d at a r a te of 100 m g a day. T h e pa t i en t ' s condi t ion d e t e r i o r a t e d rapidly; anasa rca , severe p re - rena l azo temia , a n d hepa t i c e n c e p h a l o p a t h y deve loped , t h e p lasmapheres i s shun t b e c a m e occ luded by clot, a n d his a r m b e c a m e w a r m a n d swollen. A chest r a d i o g r a p h showed inf i l t ra tes . Staphy-lococcus aureus g r e w in b lood cul tures . Sept ic shock devel-o p e d , a n d the pa t ien t d ied on t h e 30 th hospi tal day. He-molyt ic c o m p l e m e n t analysis revea led absence of C2 , con-sistent with h o m o z y g o u s def ic iency. T h e pa t i en t ' s H L A type was A 2 5 B18 Dr2 . P o s t m o r t e m e x a m i n a t i o n showed e n d o -cardi t is involving t h e t r iscuspid valve; permiss ion f o r ex-a m i n a t i o n of t h e digital a r t e r i e s was no t o b t a i n e d .

Discussion Glass et al' surveyed 509 blood bank donors

and found that 1.2% had heterozygous C3 defi-ciency, suggesting that the frequency of homo-zygous deficiency is approximately 1 in 30,000. A survey of patients with rheumatic disease re-

vealed a 3.7% prevalence of heterozygous defi-ciency in patients with juvenile rheumatoid ar-thritis and 5.9% in patients with SLE."' Thus while partial C2 deficiency is not uncommon in the general population, it is more frequently as-sociated with rheumatic disease.

Several cases of C2 deficiency associated with chronic vasculitis have been described. Friend et al8 described a patient with a 23-year history of inflammatory arthritis, Raynaud's phenomenon, and a mononeuropathy multiplex. Several pa-tients with C2 deficiency and anaphylactoid pur-pura have been described.21417 All had recurrent purpuric eruptions, often following upper respi-ratory infections, and one also had focal glomer-ulonephritis.17 Another patient had cryoglobu-lins, though they were not characterized.18

All had markedly decreased C2 as measured by functional assay, and 1 had decreased factor B.L

In contrast to these cases of vasculitis, our patient's course was rapidly terminal, with only 10 weeks intervening between the onset of digital gangrene and death. Since permission for post-mortem examination of the extremities was not obtained, we could not obtain pathological evi-dence of vasculitis of the digital arteries. No evidence of vasculitis was seen in the kidneys or lungs. While it could be postulated that throm-boangiitis obliterans was responsible for the dig-ital gangrene, this is unlikely; the course of his illness was unusually rapid, neither superficial nor deep thrombophlebitis was present, and, most importantly, his gangrene progressed despite ab-stinence from tobacco. His right-sided endocar-ditis could not explain the entire course of his illness and was considered to be agonal; more-over, multiple blood cultures, echocardiography, and cardiac catheterization had failed to reveal evidence of endocarditis on admission. The pres-ence of immune complexes and the characteristic angiogram further supported the diagnosis of vasculitis as the cause of the digital gangrene.

The precise role of immune complexes in the pathogenesis of our patient's disorder is unclear. Alternative mechanisms must be considered, since terminal activation of the complement cas-cade via the usual pathway would be impossible. One possibility is activation of an alternate path-way by either the appropriate antigen or IgA or IgG4 immunoglobulins, as supported by the de-tection of IgA in the cryoprecipitate. The pres-ence of activated C3 in the serum, combined with the normal level of non-activated C3, implies a

Page 3: Fulminating vasculiti ins a homozygous C2-deficient patient...pathway coul explaid thn e fulminatin vasculitig s seen in our patient. Leonard H. Calabrese D.O, . Department of Rheumati

Summer 1985 Fulminating vasculitis 215

low level of activation; in view of the normal C4 levels and homozygous C2 deficiency, activation of an alternate pathway seems likely.

Another possible pathogenic mechanism con-siders the potential effect of the complement system on the normal circulation and clearance of immune complexes. It has been de-monstrated18 that the solubility of immune com-plexes is greatly impeded in C2-deficient sera, thereby exerting a protective effect in vivo by solubilizing large antigen-antibody aggregates which may cause tissue damage. Furthermore, decreased solubility may lead to impaired clear-ance, a prolonged circulatory half-life, and in-creased tissue deposition.19 Lastly, all of these interactions may be influenced by the presence of immune complexes, which can themselves in-fluence immunoregulation. Depending on the system used, Clough et al20 demonstrated both immunologic enhancement and inhibition of sup-pressor cell function in the presence of immune complexes.

The reason for the association of C2 deficiency with rheumatic disease is not known; hypotheses have included an immune response gene associ-ated with an HLA haplotype and decreased viral neutralization. Defective immune complex solu-bility with subsequent activation of an alternative pathway could explain the fulminating vasculitis seen in our patient.

Leonard H. Calabrese, D.O. Department of Rheumatic Disease The Cleveland Clinic Foundation 9500 Euclid Ave. Cleveland OH 44106

References 1. Glass D, Raum D, Gibson D, Stillman JS, Schur

PH. Inherited deficiency of the second component o f com-plement. J Clin Invest 1976; 58:853-861 .

2. Sussman M.JonesJH, AlmeidaJD, Lachmann PJ. Deficiency of the second component of complement associated with anaphylactoid purpura and presence of mycoplasma in the serum. Clin Exp Immunol 1973; 14:531-539 .

3. Leddy JP, Griggs RC, Klemperer MR, Frank MM. Hereditary complement (C2) deficiency with dermato-myositis. Am J Med 1975; 58:83-91 .

4. Slade JD, Luskin A T , Gewürz H, Kraft SC, Kirsner JB, Zeitz HJ. Inherited deficiency of second component o f comple-ment and HLA haplotype A10 , B18 associated with inflam-matory bowel disease. Ann Intern Med 1978; 8 8 : 7 9 6 - 7 9 8 .

5. RiggsJE, Griggs RC, Rosenfeld SI, May AG, Penn AS. Het-erozygous C2-deficiency and myasthenia gravis. Neurology 1980; 30 :871-873 .

6. Arala-Chaves MP, Fundenberg HH, Boackle RJ, Ainsworth SK, Mello-Vieira R. A case of "common variable immuno-deficiency" with reduced C2 activity and multiple associations. Clin Immunol Immunopathol 1980; 17 :227-234 .

7. Loirat C, Levy M, Peltier AP, Broyer M, Checoury A, Mathieu H. Deficiency of the second component of complement; its occurrence with membranoproliferative glomerulonephritis. Arch Pathol Lab Med 1980; 104:467-472 .

8. Friend P, Repine JE, Youngki K, Clawson CC, Michael AF. Deficiency of the second component of complement (C2) with chronic vasculitis. Ann Intern Med 1975; 8 3 : 8 1 3 -819.

9. Gewürz A, Lint TF, Roberts JL, Zeitz H, Gewürz H. Homozygous C2 deficiency with fulminant lupus ery-thematosus: severe nephritis via the alternative complement pathway. Arthritis Rheum 1978; 21:28-36 .

10. Roberts JL, Schwartz MM, Lewis EJ. Hereditary C2 defi-ciency and systemic lupus erythematosus associated with se-vere glomerulonephritis. Clin Exp Immunol 1978; 3 1 : 3 2 8 -338.

11. Sampson HA, Walchner AM, Baker PJ. Recurrent pyogenic infections in individuals with absence of the second component of complement. J Clin Immunol 1982; 2 :39-45 .

12. Repine JE, Clawson CC, Friend PS. Influence of a deficiency of the second component of complement on the bactericidal activity of neutrophils in vitro. J Clin Invest 1977; 5 9 : 8 0 2 -809.

13. Clough JD, Mansfield LR. Use of C6- and C7-deficient human sera in quantitative hemolytic assays for C6 and C7. J Immunol Methods 1979; 3 0 : 2 0 1 - 2 0 7 .

14. Laureil CB. Antigen-antibody crossed electrophoresis. Anal Biochem 1965; 10 :358-361 .

15. Mayer M. Complement and complement fixation. [In] Kabat EA, ed. Experimental Immunochemistry. 2nd ed. Springfield 111, Charles C Thomas, 1971, pp 133 -240 .

16. Glass D, Schur PH. Inherited deficiency of the second com-ponent of complement: HLA linkage and rheumatic disease associations. Clin Rheum Dis 1978; 4 : 6 0 3 - 6 1 5 .

17. Einstein LP, Alper CA, Block KJ, et al. Biosynthetic defect in monocytes from human beings with genetic deficiency of the second component of complement. N Engl J Med 1975; 292:1169-1171 .

18. Gelfand EW, Clarkson JE, Minta JO. Selective deficiency of the second component of complement in a patient with ana-phylactoid purpura. Clin Immunol Immunopathol 1975; 4 :269-276 .

19. Takahashi M, Takahashi S, Hirose S. Solubilization of antigen-antibody complexes; a new function of complement as regu-lator of immune reactions. Prog Allergy 1980; 2 7 : 1 3 4 - 1 6 6 .

20. Clough JD, Getzy DM, Calabrese LH, Frank SA, Mazanec DJ. Immune complexes and immunoregulation. [In] Krakauer RS, Cathcart MK, eds. Immunoregulation and Immunity. Amsterdam, Elsevier North Holland, 1980, pp 2 1 - 2 8 .